Fezolinetant CAS 1629229-37-3 high quality can be supplied from stock
2 Inquiries
1629229-37-3
Pharmaceutical Grade
99%
Million
25kg/Cardboard Drum
2024-09-13
Apixaban Repotrectinib/TPX-0005,Edoxaban,Lurasidone,Elacestrant,Bexagliflozin,Baricitinib
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Fezolinetant
Other Name:Fezolinetant;1629229-37-3;ESN-364;ESN364;UNII-83VNE45KXX;83VNE45KXX;CHEMBL3608680;A2693;AS3472693-00;Fezolinetant [USAN]
CAS No.:1629229-37-3
Molecular Formula:C16H15FN6OS
InChIKeys:PPSNFPASKFYPMN-SECBINFHSA-N
Molecular Weight:358.4
Exact Mass:358.10120846
UNII:83VNE45KXX
Categories:
Characteristics -
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Apixaban Repotrectinib/TPX-0005,Edoxaban,Lurasidone,Elacestrant,Bexagliflozin,Baricitinib
-
Location:
Room1-2208,Lianhecaifu Square,No2177,Tianchen road,Gaoxin district
-
Payment Terms:
TT against copy of documents,L/C,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
3
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
51-100
-
Year of Establishment:
2012
-
Certifications:
certification of high-tech enterprise
-
-
Inquiry History2 Inquiries
Country Product Purchase Quantity Date Posted
Pakistan
FEZOLINETANT
450 G Feb 14, 2025
Bangladesh
Fezolinetant
50 KG Dec 31, 2024 Post an enquiry for this product
Fezolinetant is an oral small molecule neurokinin-3 receptor (NK3R) antagonist developed by Astellas Pharma Inc. for the treatment of moderate to severe vasoconstrictive symptoms (VMS) or menopausal hot flashes. Fezolinetant is a non hormonal strategy that regulates neuronal activity related to temperature regulation by inhibiting NK3R mediated signaling in the central nervous system, thereby reducing the frequency and severity of VMS.


